Using alternative statistical formats for presenting risks and risk reductions.

PubWeight™: 1.81‹?› | Rank: Top 3%

🔗 View Article (PMID 21412897)

Published in Cochrane Database Syst Rev on March 16, 2011

Authors

Elie A Akl1, Andrew D Oxman, Jeph Herrin, Gunn E Vist, Irene Terrenato, Francesca Sperati, Cecilia Costiniuk, Diana Blank, Holger Schünemann

Author Affiliations

1: Department of Medicine, State University of New York at Buffalo, ECMC CC-142, 462 Grider Street, Buffalo, NY, USA, 14215.

Articles citing this

Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (2013) 2.25

Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers. BMC Med Inform Decis Mak (2013) 1.99

Heatwave early warning systems and adaptation advice to reduce human health consequences of heatwaves. Int J Environ Res Public Health (2011) 1.94

Do clinicians understand the size of treatment effects? A randomized survey across 8 countries. CMAJ (2015) 1.54

Presentation of Benefits and Harms in US Cancer Screening and Prevention Guidelines: Systematic Review. J Natl Cancer Inst (2016) 1.42

SUPPORT Tools for evidence-informed health Policymaking (STP) 16: Using research evidence in balancing the pros and cons of policies. Health Res Policy Syst (2009) 1.30

Patient-reported outcomes in meta-analyses-part 2: methods for improving interpretability for decision-makers. Health Qual Life Outcomes (2013) 1.06

On the Supposed Evidence for Libertarian Paternalism. Rev Philos Psychol (2015) 1.03

A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: lessons for tool developers. BMC Health Serv Res (2013) 0.95

Impact of selective evidence presentation on judgments of health inequality trends: an experimental study. PLoS One (2013) 0.92

The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer. BMJ Open (2013) 0.92

I don't believe it, but i'd better do something about it: patient experiences of online heart age risk calculators. J Med Internet Res (2014) 0.92

Presenting evidence-based health information for people with multiple sclerosis: the IN-DEEP project protocol. BMC Med Inform Decis Mak (2012) 0.92

Natural frequencies facilitate diagnostic inferences of managers. Front Psychol (2015) 0.88

A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol. Syst Rev (2013) 0.87

Communicating cardiovascular disease risk: an interview study of General Practitioners' use of absolute risk within tailored communication strategies. BMC Fam Pract (2014) 0.87

Communicating the benefits and harms of colorectal cancer screening needed for an informed choice: a systematic evaluation of leaflets and booklets. PLoS One (2014) 0.86

Web search behavior and information needs of people with multiple sclerosis: focus group study and analysis of online postings. Interact J Med Res (2014) 0.85

Development and assessment of a website presenting evidence-based information for people with multiple sclerosis: the IN-DEEP project. BMC Neurol (2016) 0.83

Physician preferences for extra-glycemic effects of type 2 diabetes treatments. Diabetes Ther (2013) 0.82

Improving the user experience of patient versions of clinical guidelines: user testing of a Scottish Intercollegiate Guideline Network (SIGN) patient version. BMC Health Serv Res (2016) 0.81

Development and Testing of Shared Decision Making Interventions for Use in Emergency Care: A Research Agenda. Acad Emerg Med (2016) 0.81

Presenting the improved possibility for staying well might be better than talking about change in risk: use of the non-occurrence probability increase (NOPI). Scand J Prim Health Care (2013) 0.80

Critical appraisal training increases understanding and confidence and enhances the use of evidence in diverse categories of learners. Health Expect (2012) 0.79

The cycle of bias in health research: a framework and toolbox for critical appraisal training. Account Res (2013) 0.78

Interventions and assessment tools addressing key concepts people need to know to appraise claims about treatment effects: a systematic mapping review. Syst Rev (2016) 0.77

Presentation of Diagnostic Information to Doctors May Change Their Interpretation and Clinical Management: A Web-Based Randomised Controlled Trial. PLoS One (2015) 0.77

Comparison between the standard and a new alternative format of the Summary-of-Findings tables in Cochrane review users: study protocol for a randomized controlled trial. Trials (2015) 0.76

Providing additional information about the benefits of statins in a leaflet for patients with coronary heart disease: a qualitative study of the impact on attitudes and beliefs. BMJ Open (2016) 0.75

Do Cochrane summaries help student midwives understand the findings of Cochrane systematic reviews: the BRIEF randomised trial. Syst Rev (2016) 0.75

Efficacy of Electrical Stimulators for Bone Healing: A Meta-Analysis of Randomized Sham-Controlled Trials. Sci Rep (2016) 0.75

Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry. BMJ Open (2017) 0.75

Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities. Thromb Res (2015) 0.75

Breast cancer risk is increased in the years following false-positive breast cancer screening. Eur J Cancer Prev (2016) 0.75

Establishing a library of resources to help people understand key concepts in assessing treatment claims-The "Critical thinking and Appraisal Resource Library" (CARL). PLoS One (2017) 0.75

Articles by these authors

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (2008) 33.10

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14

Grading quality of evidence and strength of recommendations. BMJ (2004) 26.08

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77

Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82

Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev (2012) 10.32

GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol (2011) 10.02

Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (2008) 9.98

Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86

Going from evidence to recommendations. BMJ (2008) 7.30

Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res (2004) 7.20

Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database Syst Rev (2009) 7.07

What is "quality of evidence" and why is it important to clinicians? BMJ (2008) 6.99

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol (2014) 6.62

Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med (2011) 6.56

An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00

Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA (2010) 5.90

GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol (2010) 5.78

Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ (2009) 5.68

Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev (2009) 5.57

A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol (2005) 5.43

An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). J Clin Epidemiol (2011) 5.10

Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ (2004) 4.53

Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11

SUPPORT Tools for evidence-informed health Policymaking (STP). Health Res Policy Syst (2009) 3.93

Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. CMAJ (2003) 3.92

Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation (2005) 3.78

A new 'mechanistic-practical" framework for designing and interpreting randomized trials. J Clin Epidemiol (2008) 3.75

Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. CMAJ (2009) 3.65

GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol (2010) 3.60

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58

GRADE guidelines 6. Rating the quality of evidence--imprecision. J Clin Epidemiol (2011) 3.54

The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med (2010) 3.47

Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA (2005) 3.46

SUPPORT Tools for evidence-informed health Policymaking (STP) 14: Organising and using policy dialogues to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.45

Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45

GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44

SUPPORT Tools for evidence-informed health Policymaking (STP) 13: Preparing and using policy briefs to support evidence-informed policymaking. Health Res Policy Syst (2009) 3.34

Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol (2012) 3.34

Patients at the center: in our practice, and in our use of language. ACP J Club (2004) 3.32

GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30

Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews. Lancet (2008) 3.28

Quality of care in for-profit and not-for-profit nursing homes: systematic review and meta-analysis. BMJ (2009) 3.22

Assessing the impact of a cooperative group trial on breast cancer care in the medicare population. J Clin Oncol (2012) 3.07

GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02

A checklist for identifying determinants of practice: a systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement Sci (2013) 3.00

Health and social services expenditures: associations with health outcomes. BMJ Qual Saf (2011) 2.98

Evaluating obstetrical residency programs using patient outcomes. JAMA (2009) 2.93

Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement. Health Res Policy Syst (2006) 2.93

Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res (2005) 2.91

Effectiveness and cost of a transitional care program for heart failure: a prospective study with concurrent controls. Arch Intern Med (2011) 2.88

Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med (2012) 2.86

GRADE guidelines: 8. Rating the quality of evidence--indirectness. J Clin Epidemiol (2011) 2.83

Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA (2003) 2.77

Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention. PLoS Med (2006) 2.67

Cluster randomised controlled trial of tailored interventions to improve the management of urinary tract infections in women and sore throat. BMJ (2002) 2.58

Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57

Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Serv Res (2005) 2.50

GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46

Summary-of-findings tables in Cochrane reviews improved understanding and rapid retrieval of key information. J Clin Epidemiol (2010) 2.34

Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback. Qual Saf Health Care (2006) 2.27

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results. Implement Sci (2013) 2.25

Improving the use of research evidence in guideline development: 1. Guidelines for guidelines. Health Res Policy Syst (2006) 2.24

[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]. Tidsskr Nor Laegeforen (2002) 2.22

[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen (2002) 2.20

[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]. Tidsskr Nor Laegeforen (2002) 2.19

SUPPORT Tools for evidence-informed health Policymaking (STP) 4: Using research evidence to clarify a problem. Health Res Policy Syst (2009) 2.15

Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive. BMJ (2008) 2.15

Improving the use of research evidence in guideline development: 3. Group composition and consultation process. Health Res Policy Syst (2006) 2.15

Evidence-informed health policy 1 - synthesis of findings from a multi-method study of organizations that support the use of research evidence. Implement Sci (2008) 2.15

HARLOT plc: an amalgamation of the world's two oldest professions. BMJ (2003) 2.14

Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation (2011) 2.13

User testing and stakeholder feedback contributed to the development of understandable and useful Summary of Findings tables for Cochrane reviews. J Clin Epidemiol (2010) 2.12

Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force. Chest (2006) 2.08

A role for SSU72 in balancing RNA polymerase II transcription elongation and termination. Mol Cell (2002) 2.06

Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis. J Bone Joint Surg Am (2005) 2.05

SUPPORT Tools for evidence-informed health Policymaking (STP) 9: Assessing the applicability of the findings of a systematic review. Health Res Policy Syst (2009) 2.05

SUPPORT tools for evidence-informed policymaking in health 6: Using research evidence to address how an option will be implemented. Health Res Policy Syst (2009) 2.02

World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J (2010) 2.01

SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions. Health Res Policy Syst (2009) 2.00

SUPPORT Tools for evidence-informed health Policymaking (STP) 7: Finding systematic reviews. Health Res Policy Syst (2009) 1.99

Evidence summaries tailored to health policy-makers in low- and middle-income countries. Bull World Health Organ (2010) 1.94